DESCOVY® DayTracker™
INDICATION

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP® is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Help your patients keep track of their PrEP medication with the DESCOVY® DayTracker™1

  • Patients can get the DayTracker pack at no difference in cost to them vs the bottle

  • 30 visually trackable doses, with a helpful refill reminder built in

  • Convenient packaging with perforated doses

Descovy® (emtricitabine and tenofovir alafenamide) DayTracker™

Pills shown are not actual size.

The convenient packaging of the DESCOVY DayTracker pack fits into your patients' daily lives.